Jamie Samath Sells 269 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRGGet Free Report) CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Jamie Samath also recently made the following trade(s):

  • On Wednesday, January 29th, Jamie Samath sold 94 shares of Intuitive Surgical stock. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34.
  • On Tuesday, December 10th, Jamie Samath sold 270 shares of Intuitive Surgical stock. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50.
  • On Friday, November 29th, Jamie Samath sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.00, for a total value of $101,332.00.
  • On Tuesday, November 26th, Jamie Samath sold 108 shares of Intuitive Surgical stock. The shares were sold at an average price of $542.06, for a total value of $58,542.48.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $589.61 on Thursday. The stock has a market capitalization of $210.01 billion, a P/E ratio of 91.98, a P/E/G ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock’s 50-day simple moving average is $556.91 and its 200 day simple moving average is $516.98.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on ISRG shares. Jefferies Financial Group increased their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

View Our Latest Research Report on Intuitive Surgical

Institutional Trading of Intuitive Surgical

Several hedge funds and other institutional investors have recently modified their holdings of the business. ExodusPoint Capital Management LP boosted its holdings in Intuitive Surgical by 1,556.7% in the 4th quarter. ExodusPoint Capital Management LP now owns 65,176 shares of the medical equipment provider’s stock worth $34,019,000 after buying an additional 61,242 shares during the period. Grant Private Wealth Management Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $1,801,000. Spahn Wealth & Retirement LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth $4,343,000. Arete Wealth Advisors LLC grew its position in shares of Intuitive Surgical by 78.3% in the fourth quarter. Arete Wealth Advisors LLC now owns 1,908 shares of the medical equipment provider’s stock valued at $996,000 after purchasing an additional 838 shares in the last quarter. Finally, Motley Fool Asset Management LLC raised its stake in shares of Intuitive Surgical by 18.3% during the 4th quarter. Motley Fool Asset Management LLC now owns 19,248 shares of the medical equipment provider’s stock valued at $10,047,000 after purchasing an additional 2,983 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.